Literature DB >> 1233084

The results of radiotherapy for Hodgkins' disease.

M J Peckham, H T Ford, T J McElwain, C L Harmer, K Atkinson, D E Austin.   

Abstract

The results of radiation therapy in 212 patients with stages I and II Hodgkin's disease treated between 1963 and 1973 show that approximately 60% remain disease-free following treatment. Multiple node involvement in stage II, particularly associated with infraclavicular node disease, is identified as a group where the relapse rate is high. This presentation is associated particularly with NS. In a group of 78 patients treated with radiotherapy following staging laparotomy and splenectomy approximately 80% remain in complete remission. The preliminary results of treatment in PS IIIa patients are substantially the same as those for PS I and II; the results of treatment for NS and MC disease are similar. The significance of involvement of the spleen is discussed. Although it is probable that Hodgkin's disease spreads to the spleen through the blood stream it is suggested that splenic involvement does not necessarily indicate that the involvement of other extralymphatic structures such as liver and marrow has occurred. However, when the nodes in the porta hepatis are involved splenic Hodgkin's disease may well be associated with an increased risk of occult hepatic infiltration.

Entities:  

Mesh:

Year:  1975        PMID: 1233084      PMCID: PMC2024753          DOI: 10.1038/bjc.1975.239

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Organ-specific metastasis of a transplantable reticulum cell sarcoma.

Authors:  R C Parks
Journal:  J Natl Cancer Inst       Date:  1974-03       Impact factor: 13.506

2.  Analysis of primary relapses after radiotherapy in Hodgkin's disease.

Authors:  M F Spittle; C L Harmer; J R Cassady; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

3.  Combination chemotherapy and radiotherapy for Hodgkin's disease.

Authors:  S A Rosenberg; M R Moore; J M Bull; S E Jones; H S Kaplan
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

4.  Curative radiotherapy in Hodgkin's disease: significance of haematogenous dissemination established by examination of peripheral blood and spleen.

Authors:  M R Halie; J J Seldenrath; H C Stam; H O Nieweg
Journal:  Br Med J       Date:  1972-06-10

5.  Preliminary experience with total nodal irradiation in Hodgkin's disease.

Authors:  R E Johnson; L B Thomas; M Schneiderman; D W Glenn; F Faw; M D Hafermann
Journal:  Radiology       Date:  1970-09       Impact factor: 11.105

6.  Radiation therapy of Hodgkin's disease: significance of splenic involvement.

Authors:  W U Shipley; A J Piro; S Hellman
Journal:  Cancer       Date:  1974-07       Impact factor: 6.860

7.  Combined fractionated isotopic and external irradiation of the liver in Hodgkin's disease. A study of 21 patients.

Authors:  J W Kraut; H S Kaplan; M A Bagshaw
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

8.  The value of laparotomy and splenectomy in the staging of Hodgkin's disease.

Authors:  E Glatstein; J M Guernsey; S A Rosenberg; H S Kaplan
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

9.  Quantitative cytology and cytochemistry of Hodgkin's tissue labelled in vivo with tritiated thymidine.

Authors:  M J Peckham
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

View more
  7 in total

Review 1.  Hodgkin's lymphoma. II: Treatment and delayed morbidity.

Authors:  P Carde
Journal:  BMJ       Date:  1992-07-18

2.  Management of Hodgkin's disease in childhood.

Authors:  I E Smith; T J McElwain
Journal:  Arch Dis Child       Date:  1977-09       Impact factor: 3.791

3.  [Treatment results of Hodgkin's disease, stages I and II (author's transl)].

Authors:  W Gassmann; H Pralle; H Löffler; M Gluth-Stender
Journal:  Klin Wochenschr       Date:  1981-05-15

4.  Hodgkin's disease in children.

Authors:  I E Smith; M J Peckham; T J McElwain; J C Gazet; D E Austin
Journal:  Br J Cancer       Date:  1977-07       Impact factor: 7.640

5.  Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation.

Authors:  P R Thomas; D Winstanly; M J Peckham; D E Austin; M A Murray; H S Jacobs
Journal:  Br J Cancer       Date:  1976-02       Impact factor: 7.640

6.  Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

Authors:  S B Kaye; C A Juttner; I E Smith; A Barrett; D E Austin; M J Peckham; T J McElwain
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640

7.  A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.

Authors:  H Anderson; D P Deakin; J Wagstaff; J M Jones; I D Todd; P M Wilkinson; R D James; W P Steward; G Blackledge; J H Scarffe
Journal:  Br J Cancer       Date:  1984-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.